Search by Drug Name or NDC

    NDC 72336-0064-30 Metformin Hydrochloride 625 mg/1 Details

    Metformin Hydrochloride 625 mg/1

    Metformin Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by LifSa Drugs, LLC. The primary component is METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 72336-0064
    Product ID 72336-064_ffd1c048-c170-7a9e-e053-6294a90ac00c
    Associated GPIs 27250050000330
    GCN Sequence Number 083400
    GCN Sequence Number Description metformin HCl TABLET 625 MG ORAL
    HIC3 C4L
    HIC3 Description ANTIHYPERGLYCEMIC, BIGUANIDE TYPE
    GCN 52356
    HICL Sequence Number 004763
    HICL Sequence Number Description METFORMIN HCL
    Brand/Generic Generic
    Proprietary Name Metformin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Metformin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 625
    Active Ingredient Units mg/1
    Substance Name METFORMIN HYDROCHLORIDE
    Labeler Name LifSa Drugs, LLC
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075972
    Listing Certified Through 2024-12-31

    Package

    NDC 72336-0064-30 (72336006430)

    NDC Package Code 72336-064-30
    Billing NDC 72336006430
    Package 30 TABLET in 1 BOTTLE (72336-064-30)
    Marketing Start Date 2022-05-01
    NDC Exclude Flag N
    Pricing Information N/A